Healthcare Services

Global Gouty Arthritis Market Expected to Reach $5.06 Billion by 2030 with 6.4% CAGR

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Gouty Arthritis Market By The End Of 2030?

The gouty arthritis market has experienced significant expansion in recent years. It is projected to increase from $3.69 billion in 2025 to $3.96 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.2%. Factors contributing to its historical growth include changes in dietary patterns, the accessibility of NSAIDs, a rise in arthritis diagnoses, the expansion of rheumatology clinics, and the development of pain management medications.

The gouty arthritis market size is forecasted to witness significant expansion over the next few years. It is projected to reach $5.06 billion by 2030, progressing at a compound annual growth rate (CAGR) of 6.4%. This growth during the forecast period can be attributed to factors such as an expanding aging population, increased chronic disease awareness, a focus on preventive arthritis care, enhanced patient compliance, and the adoption of personalized gout treatment approaches. Prominent trends expected in this period involve the increasing prevalence of hyperuricemia, a rising demand for long-term disease management solutions, the development of combination drug therapies, wider adoption of improved diagnostic imaging techniques, and the expansion of lifestyle-based disease management strategies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16070&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Gouty Arthritis Market?

The expanding occurrence of obesity is projected to boost the expansion of the gouty arthritis market in the future. Obesity, a medical condition, involves an excessive accumulation of body fat that poses risks to health, commonly assessed via the body mass index (BMI). The incidence of obesity is climbing, driven by greater intake of calorie-dense, processed foods and inactive routines. This condition contributes to gouty arthritis by elevating uric acid synthesis and hindering its expulsion from the body, resulting in the buildup of uric acid crystals within the joints. Furthermore, surplus body weight intensifies pressure on joints, worsening the inflammation and discomfort linked to gout. As an illustration, in May 2025, data from the Office for Health Improvement and Disparities, a UK-based government entity, indicated that between 2023 to 2024, approximately 64.5% of adults aged 18 and over in England were categorized as overweight or obese. This figure represents an increase from 64.0% recorded in 2022 to 2023. Consequently, the rising occurrence of obesity is fueling the expansion of the gouty arthritis market.

Which Segment Classifications Shape The Gouty Arthritis Market?

The gouty arthritis market covered in this report is segmented –

1) By Type: Acute Gouty Arthritis, Chronic Gouty Arthritis

2) By Treatment: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Pain Reliever, Corticosteroids, Xanthine Oxidase Inhibitors, Uricosurics, Other Treatments

3) By Diagnosis: Joint Fluid Test, Blood Test, X-Ray Imaging, Ultrasound, Dual Energy Computed Tomography (CT) Scan, Other Diagnosis

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels

5) By End-Users: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Acute Gouty Arthritis: Monosodium Urate Crystals-Induced Acute Gout, Acute Gout Attack (Intermittent Flares), Severe Acute Gout With Joint Deformities

2) By Chronic Gouty Arthritis: Tophaceous Gout (Presence Of Uric Acid Deposits), Chronic Gout With Joint Damage, Chronic Gout With Renal Complications, Chronic Gout With Comorbidities (Hypertension, Diabetes)

What Trends Are Affecting The Expansion Of The Gouty Arthritis Market?

Leading companies operating within the gouty arthritis market are enhancing their efforts to develop new products, such as cortrophin gel, to provide more effective and targeted therapies for managing the condition. Cortrophin gel, also known as repository corticotropin injection, is a purified form of the adrenocorticotropic hormone (ACTH). It is utilized to treat various inflammatory and autoimmune conditions, including gouty arthritis. For instance, in October 2023, ANI Pharmaceuticals, a US-based pharmaceutical company, obtained approval from the Food and Drug Administration for a new 1-mL vial size of Purified Cortrophin Gel. This product is intended for the adjunctive treatment of certain patients experiencing acute gouty arthritis flares. Currently, Cortrophin Gel is the only FDA-approved adrenocorticotropic hormone (ACTH) therapy indicated for treating appropriate patients with acute gouty arthritis flares.

Which Companies Are Expanding Their Footprint In The Gouty Arthritis Market?

Major companies operating in the gouty arthritis market are Horizon Therapeutics plc, Pfizer Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., Bayer AG, Bristol Myers Squibb, Novartis International AG, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., AstraZeneca plc, GlaxoSmithKline plc, Teijin Pharma Ltd, Regeneron Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, JW Pharmaceutical, Arthrosi Therapeutics Ltd, XORTX Therapeutics Inc, Atom Therapeutics Co Ltd, Olatec Therapeutics LLC, InventisBio Co Ltd, Shanton Pharma, Selecta Biosciences Inc, LG Chem Ltd, Protalix BioTherapeutics Inc

Read the full gouty arthritis market report here:

https://www.thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report

Which Regions Are Projected To Dominate The Gouty Arthritis Market In The Coming Years?

North America was the largest region in the gouty arthritis market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the gouty arthritis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Gouty Arthritis Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16070&type=smp

Browse Through More Reports Similar to the Global Gouty Arthritis Market 2026, By The Business Research Company

Gouty Arthritis Global Market Report

https://www.thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report

Ursolic Acid Global Market Report

https://www.thebusinessresearchcompany.com/report/ursolic-acid-global-market-report

Anti Inflammatory Therapeutics Global Market Report

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795